Browsing NTU Scholars | NTU Scholars

Showing results 1 to 20 of 145 next >

Issue Date	Title	Author(s)	Source	scopus	WOS
2008	Adenoid cystic carcinoma of the breast arising in a lipoma mimicking hamartoma: Imaging manifestations and review of the literature	Kuo P.-H.; Huang C.-S.; Huang W.-C.; SUNG-HSIN KUO ; Wang J.	Chinese Journal of Radiology
2016	Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion	Liang T.H.-K.; SUNG-HSIN KUO ; Wang C.-W.; Chen W.-Y.; Hsu C.-Y.; Lai S.-F.; Tseng H.-M.; You S.-L.; Chen C.-M.; Tseng W.-Y.I.	Radiotherapy and Oncology		26
2017	Association between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative status	SUNG-HSIN KUO ; Huang C.-S.	Translational Cancer Research	2	2
2017	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	Yang S.-H.; Lee J.-C.; Guo J.-C.; SUNG-HSIN KUO ; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.	PLoS ONE	4	3
2016	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	Yang S.-H.; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; SUNG-HSIN KUO	Journal of Gastroenterology and Hepatology (Australia)	7	7
2009	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; SUNG-HSIN KUO ; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L.	Journal of Hepatology	37	39
2015	AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-B activation	Tsai H.-J.; Shih N.-Y.; SUNG-HSIN KUO ; Cheng A.-L.; Lin H.-Y.; Chen T.-Y.; Chang K.-C.; Lin S.-F.; Chang J.S.; Chen L.-T.	Leukemia and Lymphoma	4	0
2017	The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)	SUNG-HSIN KUO ; Tsai H.-J.; Lin C.-W.; Yeh K.-H.; Lee H.-W.; Wei M.-F.; Shun C.-T.; Wu M.-S.; Hsu P.-N.; Chen L.-T.; Cheng A.-L.	Journal of Pathology	10	10
2014	Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse	SUNG-HSIN KUO ; Tsai H.-J.; Weng W.-H.; Li C.-C.; Yeh K.-H.; Chen L.-T.; Cheng A.-L.	Genes Chromosomes and Cancer	3	3
2018	The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation	Lai S.-F.; Chen Y.-H.; Liang T.H.-K.; Hsu C.-Y.; Lien H.-C.; Lu Y.-S.; Huang C.-S.; SUNG-HSIN KUO	Journal of Neuro-Oncology	2	2
1996	Case report: Reversible systolic heart failure and deep jaundice in hyperthyroidism	Lee T.-M.; SUNG-HSIN KUO ; Lee Y.-T.	American Journal of the Medical Sciences	12	9
2008	Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy	Ho C.-C.; SUNG-HSIN KUO ; Huang P.-H.; Huang H.-Y.; Yang C.-H.; Yang P.-C.	Lung Cancer	100	95
2017	Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas	Ma W.-L.; Yao M.; Liao S.-L.; Tang J.-L.; Wang Y.-C.; SUNG-HSIN KUO ; Cheng A.-L.	Oncotarget	5	3
2021	Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy	Lin P.-H.; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; SUNG-HSIN KUO ; Huang C.-S.	Frontiers in Oncology	1	1
2020	Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; SUNG-HSIN KUO	Clinical and Translational Radiation Oncology	5	4
2013	Clinicopathologic features and responses to radiotherapy of myeloid sarcoma	Chen W.-Y.; Wang C.-W.; Chang C.-H.; Liu H.-H.; Lan K.-H.; Tang J.-L.; Tien H.-F.; SUNG-HSIN KUO ; Cheng A.-L.	Radiation Oncology	20	21
2009	Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients	Lin Y.-C.; Tsai C.-H.; Wu J.-S.; Huang C.-S.; SUNG-HSIN KUO ; Lin C.-W.; Cheng A.-L.	Leukemia and Lymphoma	25	20
2010	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; Hsu C.-H.; Lu Y.-S.; Cheng A.-L.	Cancer letters	19	19
2021	Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas	Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; SUNG-HSIN KUO	Journal of the Formosan Medical Association	1	1
2006	Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin	Lin C.-H.; Kuo K.-T.; Chuang S.-S.; SUNG-HSIN KUO ; Chang J.H.; Chang K.-C.; Hsu H.-C.; Tien H.-F.; Cheng A.-L.	Clinical Cancer Research	101	89

Showing results 1 to 20 of 145 next >

DSpace CRIS

Browsing by Author